DUPILUMAB

DUPILUMAB (15012D)

dupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL pen devices
15012D
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment

Restriction

Indication: Uncontrolled severe asthma
Treatment phase: Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 5 DPMQ: $1,658.74 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Dupixent